Clinical Trials on Glabellar Crease in United Kingdom
Total 7463 results
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedHER2/Neu Positive | Ductal Breast Carcinoma In SituUnited States
-
Massachusetts General HospitalRecruitingBreast Reductions | Drain Output After Breast Reduction SurgeryUnited States
-
Adrienne G. WaksGilead SciencesActive, not recruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
Deborah DoroshowRecruitingPTEN-Altered Advanced Solid Tumors and HER2 Negative Breast CancerUnited States
-
Aultman Health FoundationTerminatedMetastatic Breast Cancer | Thyroid DysfunctionUnited States
-
University of PittsburghAmerican Nurses FoundationCompletedPregnancy Related | Breast Feeding | Milk Expression, BreastUnited States
-
Medstar Health Research InstituteGenentech, Inc.TerminatedHER-2 Positive Metastatic Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States
-
University of Kansas Medical CenterActive, not recruitingHER2-positive Breast CancerUnited States
-
University of California, San DiegoWithdrawnStage, Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, France, Sweden, Canada, Finland, Italy, Greece, Mexico, Costa Rica, Poland, Brazil, Guatemala, Panama
-
M.D. Anderson Cancer CenterNot yet recruitingBreast CancerUnited States
-
Mayo ClinicCompletedBreast CarcinomaUnited States
-
University of ArizonaTucson Osteopathic Medical FoundationCompletedBreast CancerUnited States
-
Brigham and Women's HospitalNational Cancer Institute (NCI)Active, not recruitingBenign Breast DiseaseUnited States
-
University of MichiganWayne State UniversityCompleted
-
Immunis.AIDuke UniversityNot yet recruitingBreast Cancer | Breast Cancer FemaleUnited States
-
Herbert LyerlyMerck Sharp & Dohme LLCTerminatedBreast Cancer | HER2+ Breast CancerUnited States
-
Wake Forest University Health SciencesPfizer; Atrium Health Levine Cancer InstituteActive, not recruitingBreast Cancer | Female Breast CarcinomaUnited States
-
Washington University School of MedicineCompletedBreast Cancer | Breast CarcinomaUnited States
-
AstraZenecaCompletedMetastatic Breast CancerUnited States
-
New Mexico Cancer Care AllianceCompletedBreast Cancer ScreeningUnited States
-
University of Southern CaliforniaCompleted
-
Dartmouth-Hitchcock Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedAdvanced Breast CancerUnited States
-
University of OklahomaCompletedMetastatic Breast CancerUnited States
-
University of Missouri-ColumbiaNational Cancer Institute (NCI); National Institutes of Health (NIH)Recruiting
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Breast Cancer FemaleUnited States
-
Henry Ford Health SystemActive, not recruitingBreast Cancer FemaleUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI)WithdrawnBreast Cancer FemaleUnited States
-
Western Regional Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Janssen Diagnostics, LLCThe Cleveland ClinicWithdrawnBreast Cancer | Metastatic Breast CancerUnited States
-
M.D. Anderson Cancer CenterCompletedInvasive Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene MutationUnited States
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast Carcinoma and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBone Metastases | Lung Metastases | HER2-positive Breast Cancer | Liver Metastases | Stage IV Breast Cancer | Recurrent Breast Cancer | Soft Tissue MetastasesUnited States
-
University of ArkansasCompletedBreast Neoplasms | Triple Negative Breast CancerUnited States
-
Ambry GeneticsCompletedBreast Cancer RiskUnited States
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
University of Michigan Rogel Cancer CenterRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast CarcinomaUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)Not yet recruitingTriple Negative Breast Cancer (TNBC)United States
-
Deborah Farr, MDRecruitingBreast Cancer | High Risk of Breast CancerUnited States
-
Kind Pharmaceuticals LLCRecruitingAdvanced or Metastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingInvasive Breast Cancer | Post-mastectomyUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron PharmaceuticalsCompletedHormone Receptor-positive Breast CancerUnited States
-
University of Illinois at ChicagoNational Cancer Institute (NCI)CompletedHigh Risk for Breast CancerUnited States